Literature DB >> 28181672

Endometriosis increases the risk of obstetrical and neonatal complications.

Janne Foss Berlac1, Dorthe Hartwell2, Charlotte Wessel Skovlund2, Jens Langhoff-Roos3, Øjvind Lidegaard2.   

Abstract

INTRODUCTION: The objective of this study was to assess obstetrical complications and neonatal outcomes in women with endometriosis as compared with women without endometriosis.
MATERIAL AND METHODS: National cohort including all delivering women and their newborns in Denmark 1997-2014. Data were extracted from the Danish Health Register and the Medical Birth Register. Logistic regression analysis provided odds ratios (OR) with 95% confidence intervals (CI). Sub-analyses were made for primiparous women with a singleton pregnancy and for women with endometriosis who underwent gynecological surgery before pregnancy.
RESULTS: In 19 331 deliveries, women with endometriosis had a higher risk of severe preeclampsia (OR 1.7, 95% CI 1.5-2.0), hemorrhage in pregnancy (OR 2.3, 95% CI 2.0-2.5), placental abruption (OR 2.0, 95% CI 1.7-2.3), placenta previa (OR 3.9, 95% CI 3.5-4.3), premature rupture of membranes (OR 1.7, 95% CI 1.5-1.8), and retained placenta (OR 3.1, 95% CI 1.4-6.6). The neonates had increased risks of preterm birth before 28 weeks (OR 3.1, 95% CI 2.7-3.6), being small for gestational age (OR 1.5, 95% CI 1.4-1.6), being diagnosed with congenital malformations (OR 1.3, 95% CI 1.3-1.4), and neonatal death (OR 1.8, 95% CI 1.4-2.1). Results were similar in primiparous women with a singleton pregnancy. Gynecological surgery for endometriosis before pregnancy carried a further increased risk.
CONCLUSION: Women with endometriosis had a significantly higher risk of several complications, such as preeclampsia and placental complications in pregnancy and at delivery. The newborns had increased risk of being delivered preterm, having congenital malformations, and having a higher neonatal death rate. Pregnant women with endometriosis require increased antenatal surveillance.
© 2017 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Keywords:  Endometriosis; delivery; neonatal complications; obstetrical complications; pregnancy complications

Mesh:

Year:  2017        PMID: 28181672     DOI: 10.1111/aogs.13111

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  23 in total

Review 1.  Genetics and Epigenetics of Infertility and Treatments on Outcomes.

Authors:  Margareta D Pisarska; Jessica L Chan; Kate Lawrenson; Tania L Gonzalez; Erica T Wang
Journal:  J Clin Endocrinol Metab       Date:  2019-06-01       Impact factor: 5.958

2.  Evidence for shared molecular pathways of dysregulated decidualization in preeclampsia and endometrial disorders revealed by microarray data integration.

Authors:  Maria Belen Rabaglino; Kirk P Conrad
Journal:  FASEB J       Date:  2019-08-07       Impact factor: 5.191

3.  Diagnosis and Treatment of Endometriosis. Guideline of the DGGG, SGGG and OEGGG (S2k Level, AWMF Registry Number 015/045, August 2020).

Authors:  Stefanie Burghaus; Sebastian D Schäfer; Matthias W Beckmann; Iris Brandes; Christian Brünahl; Radek Chvatal; Jan Drahoňovský; Wojciech Dudek; Andreas D Ebert; Christine Fahlbusch; Tanja Fehm; Peter Martin Fehr; Carolin C Hack; Winfried Häuser; Katharina Hancke; Volker Heinecke; Lars-Christian Horn; Christian Houbois; Christine Klapp; Heike Kramer; Harald Krentel; Jan Langrehr; Heike Matuschewski; Ines Mayer; Sylvia Mechsner; Andreas Müller; Armelle Müller; Michael Müller; Peter Oppelt; Thomas Papathemelis; Stefan P Renner; Dietmar Schmidt; Andreas Schüring; Karl-Werner Schweppe; Beata Seeber; Friederike Siedentopf; Horia Sirbu; Daniela Soeffge; Kerstin Weidner; Isabella Zraik; Uwe Andreas Ulrich
Journal:  Geburtshilfe Frauenheilkd       Date:  2021-04-14       Impact factor: 2.915

4.  Endometriosis Increases the Risk of Placenta Previa in Both IVF Pregnancies and the General Obstetric Population.

Authors:  Eider Gómez-Pereira; Jorge Burgos; Rosario Mendoza; Irantzu Pérez-Ruiz; Fátima Olaso; David García; Iker Malaina; Roberto Matorras
Journal:  Reprod Sci       Date:  2022-08-23       Impact factor: 2.924

5.  Maternal and Paternal Infertility Disorders and Treatments and Autism Spectrum Disorder: Findings from the Study to Explore Early Development.

Authors:  Laura A Schieve; Carolyn Drews-Botsch; Shericka Harris; Craig Newschaffer; Julie Daniels; Carolyn DiGuiseppi; Lisa A Croen; Gayle C Windham
Journal:  J Autism Dev Disord       Date:  2017-12

6.  Effect of miR-194-5p regulating STAT1/mTOR signaling pathway on the biological characteristics of ectopic endometrial cells from mice.

Authors:  Qian Zhao; Bing Han; Ying Zhang; Ke Su; Chunfang Wang; Panpan Hai; Aiping Bian; Ruixia Guo
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

Review 7.  Endometriosis and Risk of Adverse Pregnancy Outcome: A Systematic Review and Meta-Analysis.

Authors:  Kjerstine Breintoft; Regitze Pinnerup; Tine Brink Henriksen; Dorte Rytter; Niels Uldbjerg; Axel Forman; Linn Håkonsen Arendt
Journal:  J Clin Med       Date:  2021-02-09       Impact factor: 4.241

8.  Women with Endometriosis, Especially Those Who Conceived with Assisted Reproductive Technology, Have Increased Risk of Placenta Previa: Meta-analyses.

Authors:  Hyeji Jeon; Jiwon Min; Deok Kyeong Kim; Heekyung Seo; Sunkyung Kim; Yun-Sook Kim
Journal:  J Korean Med Sci       Date:  2018-07-30       Impact factor: 2.153

9.  Endometriosis and adverse maternal, fetal and neonatal outcomes, a systematic review and meta-analysis.

Authors:  S Lalani; A J Choudhry; B Firth; V Bacal; Mark Walker; S W Wen; S Singh; A Amath; M Hodge; I Chen
Journal:  Hum Reprod       Date:  2018-10-01       Impact factor: 6.918

10.  Impact of Endometriomas and Deep Infiltrating Endometriosis on Pregnancy Outcomes and on First and Second Trimester Markers of Impaired Placentation.

Authors:  Carolina Scala; Umberto Leone Roberti Maggiore; Fabio Barra; Matteo Tantari; Simone Ferrero
Journal:  Medicina (Kaunas)       Date:  2019-08-30       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.